PAVmed

PAVM

Market cap $40.2M

PAVM Hedge Fund Activity: Q1 2026 in Review

20 of the 8,127 institutional investors tracked by Wall St. Rank reported a position in PAVmed (PAVM) for Q1 2026, worth a combined $5.2M — up 1,079% from $441K a quarter earlier.

Sellers outnumbered buyers: 13 funds closed out of PAVM and 7 opened new positions — a net loss of 6 holders — while 3 trimmed existing stakes and 9 added.

The largest buyer was Two Seas Capital, opening a new position worth an estimated $4.37M. The largest seller was UBS Group, cutting an estimated $68.6K.

• 20 institutional investors held PAVmed (PAVM) as of Q1 2026, down from 28 in Q4 2025.
• Funds reported $5.2M of PAVmed stock for Q1 2026, up 1,079% quarter-over-quarter.
• 7 funds opened new PAVmed positions in Q1 2026 and 13 closed out, a net change of -6 holders.
• The largest PAVmed buyer in Q1 2026 was Two Seas Capital, an estimated $4.37M added.
• The largest PAVmed seller in Q1 2026 was UBS Group, an estimated $68.6K sold.

Based on aggregated 13F filings for Q1 2026.